|
Watson wins FDA approval for generic Nicorette mint gum (Pharmaceutical Business Review)
Watson Pharmaceuticals has announced that its subsidiary, Watson Laboratories, Inc, has received approval from the FDA to market its over-the-counter nicotine polacrilex gum USP, coated mint flavor, in the 2mg and 4mg strengths.
Mon, 05 Jan 2009 11:05:17 GMT Watson wins U.S. OK for generic Nicorette mint gum (Reuters via Yahoo! News)
U.S. health regulators approved Watson Pharmaceuticals Inc's generic version of GlaxoSmithKline Plc's Nicorette mint gum, an over-the-counter product to help smokers quit, Watson said on Wednesday.
Wed, 31 Dec 2008 12:33:29 GMT (AFX UK Focus) 2008-12-31 12:45 UPDATE 1-Watson wins US OK for generic Nicorette mint gum (Interactive Investor)
NEW YORK, Dec 31 (Reuters) - U.S. health regulators approved Watson Pharmaceuticals Inc's generic version of GlaxoSmithKline Plc's Nicorette mint gum, an over-the-counter product to help smokers quit, Watson said on Wednesday. Watson plans to make the product, known generically as Nicotine Polacrilex gum, available in early January. Watson won approval for the 2 milligram and 4 milligram ...
Wed, 31 Dec 2008 13:03:27 GMT
|
